Product
Currency:CNY
2023/FY
Stock NameRevenueRatio
Nucleoside series463.76M55.51%
核苷酸系列146.23M17.50%
嘌呤系列146.03M17.48%
Pyrimidine series48.03M5.75%
Other31.46M3.76%
Industry
Currency:CNY
2023/FY
Stock NameRevenueRatio
Raw material medicine661.53M79.18%
Intermediate170.45M20.40%
Other business3.53M0.42%
Region
Currency:CNY
2023/FY
Stock NameRevenueRatio
Territory751.94M90.00%
Overseas83.57M10.00%